dactinomycin and crizotinib

dactinomycin has been researched along with crizotinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bradley, C; Chen, X; Chi, L; Hatfield, MJ; Potter, PM; Qu, C; Tollemar, V; Tsurkan, L; Wierdl, M	1

Other Studies

1 other study(ies) available for dactinomycin and crizotinib

Article	Year
Targeting ALK in pediatric RMS does not induce antitumor activity in vivo. Cancer chemotherapy and pharmacology, 2018, Volume: 82, Issue:2 Topics: Anaplastic Lymphoma Kinase; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Growth Processes; Cell Line, Tumor; Crizotinib; Cyclophosphamide; Dactinomycin; Drug Interactions; Humans; Mice; Mice, Nude; Molecular Targeted Therapy; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-met; Pyrimidines; Rhabdomyosarcoma; RNA, Small Interfering; Transfection; Vincristine; Xenograft Model Antitumor Assays	2018

Article

Year

Targeting ALK in pediatric RMS does not induce antitumor activity in vivo.

Cancer chemotherapy and pharmacology, 2018, Volume: 82, Issue:2

Topics: Anaplastic Lymphoma Kinase; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Growth Processes; Cell Line, Tumor; Crizotinib; Cyclophosphamide; Dactinomycin; Drug Interactions; Humans; Mice; Mice, Nude; Molecular Targeted Therapy; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-met; Pyrimidines; Rhabdomyosarcoma; RNA, Small Interfering; Transfection; Vincristine; Xenograft Model Antitumor Assays

2018